Boston Scientific (BSX) Acquisitions (2009 - 2026)

Boston Scientific has disclosed Acquisitions across 17 years of filings, most recently posting $523.0 million for Q1 2026.

• Acquisitions for Q1 2026 came in at $523.0 million, up 118.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.7 billion (down 64.94% YoY), and the FY2025 annual result was $1.6 billion, down 65.67% from the prior year.
• Acquisitions came in at $523.0 million for Q1 2026 at Boston Scientific, up from $89.0 million in the prior quarter.
• In the past five years, Acquisitions ranged from a high of $3.4 billion in Q4 2024 to a low of $47.0 million in Q1 2024.
• The 5-year median for Acquisitions is $449.0 million (2023), against an average of $709.0 million.
• Peak annual rise in Acquisitions reached 2002.08% in 2025, while the deepest fall reached 97.4% in 2025.
• Boston Scientific's Acquisitions stood at $71.0 million in 2022, then surged by 1016.9% to $793.0 million in 2023, then soared by 331.02% to $3.4 billion in 2024, then slumped by 97.4% to $89.0 million in 2025, then surged by 487.64% to $523.0 million in 2026.
• The last three Acquisitions figures came in at $523.0 million (Q1 2026), $89.0 million (Q4 2025), and $73.0 million (Q3 2025), per Business Quant data.